Mentice AB (publ) (STO:MNTC)
Sweden
· Delayed Price · Currency is SEK 21.60
+0.80 (3.85%)
Feb 21, 2025, 5:29 PM CET
Mentice AB Revenue
In the year 2024, Mentice AB had annual revenue of 291.81M SEK with 6.07% growth. Mentice AB had revenue of 87.04M in the quarter ending December 31, 2024, with 20.97% growth.
Revenue
291.81M
Revenue Growth
+6.07%
P/S Ratio
1.89
Revenue / Employee
2.21M
Employees
132
Market Cap
552.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 291.81M | 16.69M | 6.07% |
| Dec 31, 2023 | 275.12M | 55.71M | 25.39% |
| Dec 31, 2022 | 219.42M | 34.35M | 18.56% |
| Dec 31, 2021 | 185.06M | 47.56M | 34.59% |
| Dec 31, 2020 | 137.50M | -11.87M | -7.94% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 1, 2016 | Pro | Pro | Pro |
| Dec 1, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.14B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Elekta AB | 17.72B |
| Vimian Group AB | 4.29B |